So far poor trading based on potential. Lets hope analysts/investment community are watching progress and upcoming deals. If listed and dividend distributed the volume should increase. AE37 just started...........ph 3 not even close if we get there. Not being negative just the facts. As far as the 250 mil.........will find out in 2021.
AE37 link:

https://clinicaltrials.gov/ct2/show/NCT040248...amp;rank=1